Valley National Advisers’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10K | Buy |
19
+2
| +12% | +$1.12K | ﹤0.01% | 620 |
|
|
2026
Q1 | $9K | Hold |
17
| – | – | ﹤0.01% | 624 |
|
|
2025
Q4 | $11K | Hold |
17
| – | – | ﹤0.01% | 588 |
|
|
2025
Q3 | $10K | Hold |
17
| – | – | ﹤0.01% | 557 |
|
|
2025
Q2 | $9K | Sell |
17
-1
| -6% | -$478 | ﹤0.01% | 580 |
|
|
2025
Q1 | $7K | Buy |
18
+1
| +6% | +$434 | ﹤0.01% | 613 |
|
|
2024
Q4 | $7K | Sell |
17
-1
| -6% | -$439 | ﹤0.01% | 592 |
|
|
2024
Q3 | $9K | Sell |
18
-30
| -63% | -$14.6K | ﹤0.01% | 535 |
|
|
2024
Q2 | $23K | Sell |
48
-1
| -2% | -$502 | ﹤0.01% | 493 |
|
|
2024
Q1 | $26K | Buy |
49
+1
| +2% | +$546 | ﹤0.01% | 490 |
|
|
2023
Q4 | $26K | Buy |
48
+22
| +85% | +$10.3K | ﹤0.01% | 503 |
|
|
2023
Q3 | $11K | Buy |
26
+9
| +53% | +$4.49K | ﹤0.01% | 583 |
|
|
2023
Q2 | $9K | Hold |
17
| – | – | ﹤0.01% | 615 |
|
|
2023
Q1 | $9K | Hold |
17
| – | – | ﹤0.01% | 606 |
|
|
2022
Q4 | $7K | Hold |
17
| – | – | ﹤0.01% | 621 |
|
|
2022
Q3 | $6K | Hold |
17
| – | – | ﹤0.01% | 651 |
|
|
2022
Q2 | $7K | Hold |
17
| – | – | ﹤0.01% | 618 |
|
|
2022
Q1 | $9K | Hold |
17
| – | – | ﹤0.01% | 615 |
|
|
2021
Q4 | $11K | Hold |
17
| – | – | ﹤0.01% | 585 |
|
|
2021
Q3 | $11K | Hold |
17
| – | – | ﹤0.01% | 565 |
|
|
2021
Q2 | $11K | Hold |
17
| – | – | ﹤0.01% | 564 |
|
|
2021
Q1 | $8K | Hold |
17
| – | – | ﹤0.01% | 569 |
|
|
2020
Q4 | $8K | Hold |
17
| – | – | ﹤0.01% | 551 |
|
|
2020
Q3 | $7K | Hold |
17
| – | – | ﹤0.01% | 514 |
|
|
2020
Q2 | $6K | Hold |
17
| – | – | ﹤0.01% | 532 |
|
|
2020
Q1 | $4K | Hold |
17
| – | – | ﹤0.01% | 571 |
|
|
2019
Q4 | $4K | Hold |
17
| – | – | ﹤0.01% | 623 |
|
|
2019
Q3 | $5K | Hold |
17
| – | – | ﹤0.01% | 586 |
|
|
2019
Q2 | $5K | Hold |
17
| – | – | ﹤0.01% | 552 |
|
|
2019
Q1 | $4K | Hold |
17
| – | – | ﹤0.01% | 579 |
|
|
2018
Q4 | $3K | Hold |
17
| – | – | ﹤0.01% | 589 |
|
|
2018
Q3 | $4K | Hold |
17
| – | – | ﹤0.01% | 528 |
|
|
2018
Q2 | $4K | Buy |
+17
| New | +$3.5K | ﹤0.01% | 499 |
|
|
2016
Q4 | – | Sell |
-4
| Closed | – | – | 682 |
|
|
2016
Q3 | $0 | Buy |
+4
| New | +$422 | ﹤0.01% | 677 |
|
Other funds holding IDXX
Valley National Advisers's IDXX Position: Q2 2026 in Review
Valley National Advisers increased its Idexx Laboratories (IDXX) stake by 12% in Q2 2026, buying an estimated $1.12K and bringing the position to 19 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #620.
Valley National Advisers first reported a position in IDXX in Q3 2016 and has held it in 34 quarters since. The position peaked at $26K in Q1 2024. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Valley National Advisers held 19 shares of Idexx Laboratories worth $10K as of Q2 2026.
- Valley National Advisers bought 2 Idexx Laboratories shares in Q2 2026, an estimated $1.12K.
- Idexx Laboratories made up ﹤0.01% of Valley National Advisers's portfolio in Q2 2026, its #620 holding.
- Valley National Advisers first reported a position in Idexx Laboratories in Q3 2016 and has held it in 34 quarters since.
- Valley National Advisers's Idexx Laboratories position peaked at $26K in Q1 2024.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.